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Abstract 
Background: Antibiotic resistance in bacteria leads to massive health problems. Incidence of carbapenem and multi‑
drug resistance in Gram‑negative bacteria are increasing globally and turn out to be a very urgent challenge in health 
care. Resistant bacteria play an important clinical role during hospital outbreaks as well as in sepsis. Rapid diagnostic 
tests are necessary to provide immediate information for antimicrobial treatment and infection control measures.
Methods: Our mass spectrometry‑based assay was validated with 63 carbapenemase‑producing Gram‑negative 
bacterial isolates, and 35 carbapenem‑resistant Gram‑negative species with no carbapenemase production. These 
were analyzed from solid culture media and positive blood culture vials. After 4 h of incubation the carbapenemase 
products were analyzed with the MALDI‑TOF MS. All the isolates were genotyped for carbapenemase genes by PCR 
and sequencing.
Results: For culture isolates the concordance of hydrolysis assay to genetic results was 98 % for OXA variants, KPC, 
VIM, IMP, GIM, and NDM. In contrast, only 14 of 29 Acinetobacter baumannii isolates carrying the OXA and NDM genes 
could be identified from blood culture. However, from blood culture vials our method allowed the detection of car‑
bapenemases in 98 % of Pseudomonas and Enterobacteriaceae isolates harboring different genes.
Conclusions: This MALDI‑TOF MS–based assay permitted the detection of carbapenemases either from solid culture 
media (98–100 %) or blood culture vials (96 %) for all non‑A. baumannii isolates within 4 h. In case of A. baumannii 
isolates the assay was highly sensitive for the detection of carbapenemases directly from solid culture media.
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Background
The resistance of bacteria to antibiotics has increased 
in recent decades. Resistant bacteria can significantly 
complicate the treatment of infections in critically ill 
patients; especially in surgery, hemato-oncology, and 
intensive care in general [1, 2]. Recently, bacterial iso-
lates that are resistant to all available antibiotics have 
also been emerging [3, 4]. The identification and detec-
tion of specific resistance mechanisms in these bacteria 
are of paramount importance to clinical microbiologists 
for diagnosis and treatment of systemic infections, such 
as blood stream infections (BSIs), which allows for effec-
tive management of systemic infections, which allows de-
escalation from broad spectrum to targeted antibiotics, 
thus reducing overuse of carbapenems and other broad 
spectrum antibiotics. The diagnostic methods for detec-
tion of carbapenemase producers include at first level the 
antibiotic susceptibility testing results obtained by disk 
diffusion or automated systems, E-test and the verifica-
tion via modified Hodge test. However, the later method 
may lack specificity (high-level AmpC producers) and 
sensitivity, e.g. weak detection of NDM variants. Several 
technologies using molecular methods have been devel-
oped in recent years (i.e., targeted PCR assays [5, 6] and 
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peptide nucleic acid fluorescent in situ hybridization [7, 
8]). Nowadays, Matrix-assisted laser desorption ioniza-
tion–time of flight mass spectroscopy (MALDI-TOF 
MS) is increasingly utilized by clinical microbiology lab-
oratories for the identification of bacteria and yeasts [9, 
10]. MALDI-TOF MS has been performed for the detec-
tion of antimicrobial resistance, e.g. β-lactam resistance 
in Gram-negative bacteria [11, 12]. For instance, this 
method is effective for detection of carbapenemase-pro-
ducing gram-negative bacteria [9, 12–15].
Methods
Bacterial isolates
Sixty three Gram-negative bacteria, comprised of Entero-
bacteriaceae and non-fermenters, were collected by the 
National Reference Center for Gram-negative bacteria 
at the Ruhr University Bochum and at the Institute in 
Wuppertal. All of the isolates had been previously char-
acterized at the molecular level for the diverse types of 
carbapenemases (KPC, GIM, IMP, NDM, OXA, and 
VIM). As negative control, 35 non-carbapenemase-pro-
ducing, but carbapenem-resistant isolates were included. 
Species identification was performed using a MALDI-
TOF Biotyper system (Bruker Daltonics, Bremen, Ger-
many) and phenotypic antimicrobial susceptibility 
testing by use of Phoenix™ automated system (Becton–
Dickinson, Heidelberg, Germany), including ampicillin 
(±  sulbactam), piperacillin (±  tazobactam), cefuroxime, 
cefotaxime, cefepime, ceftazidime, imipenem, merope-
nem, gentamicin, ciprofloxacin, levoflocaxin, co-trimoxa-
zole, amikacin, fosfomycin, tigecycline, and colistin.
Imipenem hydrolysis assay
A colony of an overnight bacterial culture on MacConkey 
agar (Becton–Dickinson, Heidelberg, Germany) was 
washed in 1 ml H2O dest. and centrifuged at 13,200 rpm 
for 1  min, the harvested pellet was resuspended in 
20 mM Tris–HCl, 20 mM NaCl, pH 7.0, to an inoculum 
equivalent to 3.0 McFarland standard. A 1-ml aliquot of 
the suspension was centrifuged at 13,200 rpm for 1 min; 
the harvested pellet was resuspended in 50 µl of a reac-
tion buffer (20  mM Tris–HCl), pH 7.0, supplemented 
with 0.1 mM imipenem (Fresenius Kabi, Bad Homburg, 
Germany). Four hours after incubation at 37  °C in an 
Eppendorf thermomixer [agitation of 950  rpm] (Eppen-
dorf, Hamburg, Germany) the reaction mixture was cen-
trifuged at 13,200 rpm for 1 min; 1 µl of the supernatant 
was mixed with 1 µl HCCA and allowed to dry on a tar-
get. Mass spectra were measured after drying between 
160 and 700  m/z, using Microflex LT mass spectrom-
eter. Spectra were analyzed using the software program 
FlexControl, version 3.0 (Bruker Daltonics, Bremen, 
Germany). For the analysis of the hydrolysis activity 
from blood culture vials containing the Gram-negative 
bacterial isolates, 8 ml of blood culture—after 10 min at 
800 rpm—the supernatant was mixed with 200 μl of lysis 
buffer. After vortexing, the sample was centrifuged at 
13,200 rpm for 2 min, the supernatant was discarded, and 
the pellet was washed with 1 ml of deionized H2O. The 
water was thoroughly removed, and the bacterial pel-
lets (107–109 CFU) were resuspended in 10 μl of 0.1 mM 
imipenem solution and SDS (2  %). The suspension was 
incubated at 37  °C as mentioned above. Thereafter cen-
trifugation at 13,200 rpm for 2 min followed and the cell-
free supernatant was analyzed by MALDI-TOF–MS.
The absence of the imipenem  +  matrix component 
peak at 479 m/z (299 + 180 m/z) was considered as posi-
tive for the carbapenemase production, indicating the 
peaks of the degradation products with overlap of mass 
peaks. For non-carabapenemase-producing isolates, 
the complex peak of imipenem/matrix was recorded at 
479  m/z. According to these findings the interpretation 
criteria were established.
Results
Identification of relevant peaks in the MS‑spectra 
after hydrolysis assay
To generate and optimize our hydrolysis assay, we per-
formed MALDI-TOF MS analysis following different 
periods of incubation with imipenem (1, 2, 3, and 4 h—
data not shown). The assay was conducted with 3.0 of 
McFarland bacterial inoculum and 0.1  mM imipenem. 
Although after 2 h incubation time the KPC activity was 
measurable, for other enzyme variants 4 h of incubation 
was required to demonstrate significant signals of hydrol-
ysis in MALDI-TOF MS.
As a negative control MALDI-TOF MS analysis was 
performed prior to the hydrolysis assay. Differences of 
peaks in the spectra generated were recorded and sub-
sequently compared to the results gained after incuba-
tion. The MS signal of imipenem-matrix complex (Fig. 1) 
disappeared if the bacterial isolate produced carbapen-
emase. For non-carbapenemase-producing species we 
observed the signal of the complex at 479 m/z (Fig. 1).
Hydrolysis assay for carbapenemase‑producing 
Acinetobacter baumannii, Pseudomonas aeruginosa 
and different Enterobacteriaceae isolates directly 
from solid culture media
All investigated isolates were imipenem resistant as 
determined by automated susceptibility testing systems 
(BD Phoenix). In our study 38 A. baumannii isolates were 
investigated; all were positive for the genetic presence of 
carbapenemases. Twenty nine of these isolates carried the 
OXA gene variants OXA-23, -40, -58, -72, and OXA-164; 
the remaining isolates were positive for NDM-1, GIM-1 
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and VIP-2 genes. 25 P. aeruginosa and Enterobacteriaceae 
isolates were positive for different carbapenemase types. 
Seven of the later isolates produced the enzyme variant 
of OXA (Table  1). The IMP variants IMP-4 and IMP-
14 were detected in single Enterobacter cloacae isolate 
whereas, the NDM variants, NDM-1 or NDM-6, were 
carried by Escherichia coli, Klebsiella pneumoniae and 
E. cloacae isolates. The OXA variants were detected in 
6 different species, but one E. coli isolate with OXA-48 
gene did not reveal significant hydrolysis of imipenem in 
the MALDI-TOF MS analysis. None of the control iso-
lates (n  =  35, Enterobacteriaceae and non-fermenters), 
which were resistant to imipenem and meropenem but 
negative for the presence of a carbapenemase-encoding 
genes, showed hydrolysis activity in the mass spectrom-
etry, revealing 100  % specificity for the non-carbapene-
mase-producing bacteria. In brief, the sensitivity of the 
MALDI-TOF MS-based hydrolysis assay for A. bauman-
nii isolates from solid culture was 97.4 % (n = 37 of 38), 
whereas the sensitivity of 100 % was reached for the dif-
ferent Enterobacteriaceae and P. aeruginosa isolates. All 
genotyping data for other enzyme variants of carbapen-
emases are detailed in Table 1.
Hydrolysis assay directly from positive blood culture 
vials for the detection of carbapenemase‑producing 
Acinetobacter baumannii, Pseudomonas aeruginosa 
and different Enterobacteriaceae isolates
To achieve faster results with the presented assay we 
set to run the hydrolysis assay on positive blood culture 
samples. Here, a total of 38 A. baumannii isolates were 
analyzed. Fourteen of the 38 isolates carried genes for a 
carabapenemase enzyme but did not show any activity in 
the MALDI-TOF MS hydrolysis assay (Table 1). Eight of 
the 29 OXA producing isolates (OXA-23, -40, -72, -164), 
five of the seven NDM-1 isolates and one VIM-2 A. bau-
mannii isolate did not significantly show hydrolysis activ-
ity in the MALDI-TOF–MS (Table  1), although all the 
assays were performed at least in duplicate, revealing 
63.2 % sensitivity.
Additionally, 25 multidrug-resistant Enterobacteriaceae 
and P. aeruginosa isolates spiked in blood culture vials 
were analyzed. Seven of 25 isolates produced a variant 
of OXA. The other enzyme variants are given in Table 1. 
All KPC-2/-3 producing isolates (n = 5) showed signifi-
cant hydrolysis activity in the MALDI-TOF MS analysis. 
The hydrolysis activity of different class B enzymes was 
Fig. 1 MALDI‑TOF MS analysis showing the selected spectrum (range 160–800 m/z) after the performance of imipenem hydrolysis; OXA‑23 
carbapenemase‑producing A. baumannii (a) and carbapenem‑susceptible A. baumannii (b)
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Table 1 Comparison of  the genetic characteristics of  the carbapenemase genes in  A. baumannii, Pseudomonas aerugi-
nosa and Enterobacteriaceae isolates and the activity of the respective enzymes and detection of  imipenem hydrolysis 
by use of MALDI-TOF-MS directly from solid culture media and directly from positive blood culture vials
Bacterial isolates Enzyme variants
Ambler classification




 A. baumannii B (n = 9) NDM‑1a (n = 7) (n = 7)
GIM‑1 (n = 1) (n = 1)
VIM‑2 (n = 1) (n = 1)
 A. baumannii D (n = 29) OXA‑23 (n = 19) (n = 19)
OXA‑40 (n = 1) (n = 1)
OXA‑58 (n = 3) (n = 3)
OXA‑72 (n = 4) (n = 3)
OXA‑164 (n = 2) (n = 2)
 E. coli A (n = 2) KPC‑2 (n = 2) (n = 2)
 K. pneumoniae A (n = 3) KPC‑3 (n = 3) (n = 3)
 E. cloacae B (n = 2) IMP‑4, IMP‑14 (n = 2) (n = 2)
 S. marcescens B (n = 1) IMP‑13 (n = 1)
 E. cloacae B (n = 1) NDM‑1a (n = 1) (n = 1)
 E. coli B (n = 2) NDM‑1a, ‑3 (n = 2) (n = 2)
 K. pneumoniae B (n = 1) NDM‑1a (n = 1) (n = 1)
 K. pneumoniae B (n = 2) VIM‑2 (n = 2) (n = 2)
 K. oxytoca B (n = 1) VIM‑1, (n = 1) (n = 1)
 E. cloacae B (n = 1) VIM‑4 (n = 1) (n = 1)
 P. aeruginosa B (n = 2) VIM‑2 (n = 2) (n = 2)
 K. pneumoniae D (n = 4) OXA‑48 (n = 4) (n = 4)
 C. freundii D (n = 1) OXA‑162 (n = 1) (n = 1)
 E. coli D (n = 1) OXA‑181 (n = 1) (n = 1)
 K. pneumoniae D (n = 1) OXA‑204 (n = 1) (n = 1)
Blood culture vials
 A. baumannii B (n = 9) NDM‑1a (n = 7) (n = 2)
GIM‑1 (n = 1) (n = 1)
VIM‑2 (n = 1) None
 A. baumannii D (n = 29) OXA‑23 (n = 19) (n = 15)
OXA‑40 (n = 1) None
OXA‑58 (n = 3) (n = 3)
OXA‑72 (n = 4) (n = 3)
OXA‑164 (n = 2) None
 E. coli A (n = 2) KPC‑2 (n = 2) (n = 2)
 K. pneumoniae A (n = 3) KPC‑3 (n = 3) (n = 3)
 E. cloacae B (n = 2) IMP‑4, IMP‑14 (n = 2) (n = 2)
 S. marcescens B (n = 1) IMP‑13 (n = 1)
 E. cloacae B (n = 1) NDM‑1a (n = 1) (n = 1)
 E. coli B (n = 2) NDM‑1a, −3 (n = 2) (n = 2)
 K. pneumoniae B (n = 1) NDM‑1a (n = 1) (n = 1)
 K. pneumoniae B (n = 2) VIM‑2 (n = 2) (n = 2)
 K. oxytoca B (n = 1) VIM‑1, (n = 1) (n = 1)
 E. cloacae B (n = 1) VIM‑4 (n = 1) (n = 1)
 P. aeruginosa B (n = 2) VIM‑2 (n = 2) (n = 2)
 K. pneumoniae D (n = 4) OXA‑48 (n = 4) (n = 3)
 C. freundii D (n = 1) OXA‑162 (n = 1) (n = 1)
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detected. Within the Ambler class D the OXA variants 
were detected in six different species, but one E. coli iso-
late with OXA-48 gene did not reveal significant hydroly-
sis activity in the MALDI-TOF MS hydrolysis analysis 
(Table 1). Taken together the present imipenem hydroly-
sis assay was able to detect carbapenemases in 24 of 25 
(96 %) of blood cultures spiked with multidrug-resistant 
Enterobacteriaceae and P. aeruginosa. The 35 Gram-
negative control isolates from positive blood culture vials 
showed no hydrolysis effects in the mass spectrometry.
Discussion
The rapid detection of clinically important beta-lactamases 
(e.g. extended-spectrum beta-lactamases and carbapen-
emases) in routine diagnostic laboratories is crucial for 
initial antibiotic therapy for patients as well as for the pre-
vention of the spread of beta-lactamase-producing bacteria 
in health care settings. MALDI-TOF mass spectrometry 
allows clinical microbiologists to discern unique protein 
signatures, abundantly ribosomal proteins, in order to 
identify the pathogens [16]. In addition, there is potential 
for the detection of resistance mechanisms [10]. The most 
common mechanism of resistance to beta-lactams is the 
hydrolysis of the amide bond of the beta-lactam ring [10]. 
This last application includes identification of the antibi-
otic itself and its modified/degraded derivatives [9, 12–14, 
17]; detection of the resistance proteins within the cell [11, 
18], and discovery of mutations within the resistance genes 
through mini-sequencing [19, 20]. Almost 4 years ago two 
studies on direct carbapenemase detection by MALDI-
TOF MS hydrolysis assay were reported [9, 13]. An analy-
sis of antibiotics and their degradation products that are 
smaller than 1000 Da by MALDI-TOF MS is possible using 
a specific sample preparation [21]. Several studies have 
assessed the utility of MALDI-TOF mass spectrometry for 
the identification of beta-lactams and beta-lactam degra-
dation products within four hours, either from the culture 
media or positive blood culture vials [9, 12–15, 17, 22].
Jung et al. reported the detection of ampicillin and cefo-
taxime resistances in hydrolysis assays directly from blood 
cultures [22]. However, these assays can only detect the 
presence of beta-lactamases as a resistance mechanism. 
Detection of the actual proteins conferring resistance in 
such resistant bacteria by MALDI-TOF–MS seems to be 
more challenging since the protein signatures of bacteria 
are very complex. Camara and Hays [11] established a proof 
of principle for this methodology in which they dissected 
the differences between wild-type and ampicillin-resist-
ant E. coli strains. After the cultivation of resistant strains 
in broth supplemented with ampicillin, proteins were 
extracted by using a formic acid-isopropyl alcohol-water 
solution and spotted onto a MALDI-TOF MS target by a 
sandwich method using sinapinic acid as a matrix. They 
identified a 29.000 Da peak in resistant strains confirming 
that this mass/ion peak represented a beta-lactamase.
Kempf et  al. detected the carbapenemase-production 
of Gram-negative bacteria by performing the imipenem 
hydrolysis and Ultraflex MS analysis [23]. They were able 
to detect the peaks of imipenem (299 m/z) and the deg-
radation product (255 m/z) in the mass spectra. Further-
more, Sparbier et al. [17] reported that in their imipenem 
hydrolysis assay they observed a complex of imipenem 
and the matrix (190.05  m/z) at 489  m/z was observed. 
In our assay, we detected the imipenem-matrix-complex 
at 479 m/z and the peak of the matrix could be demon-
strated at 180  m/z (Fig.  1). In cases of carbapenemase-
producing isolates the peak of this complex disappeared, 
but neither degradation products nor sodium variants of 
the antibiotic of imipenem were detectable, as confirmed 
by Sparbier et  al. [17]. Moreover, we were not able to 
detect the instable hydrolysis product of imipenem.
From culture isolates our mass spectrometry-based 
imipenem hydrolysis assay correlated with the genotypic 
detection in 98  % of the cases, i.e., one OXA-48 E. coli 
isolate did not demonstrate the hydrolysis of imipenem. 
The hydrolysis activity of such enzyme might be weak as 
described previously [24]. The other OXA-48 producing 
bacteria belonged to K. pneumoniae; these showed excel-
lent hydrolysis activity in our MALDI-TOF–MS based 
hydrolysis assay. For the positive blood culture isolates, 
we were able to detect the carbapenemase activity in 
only 24 (63.2 %) of total 38 A. baumannii isolates. For the 
remaining 14 isolates no interpretation was possible con-
cerning their carbapenemase activity; these included the 
enzyme groups OXA (OXA-23, -40, and -164), NDM-1 
and VIM-2. Thus, eight of the 29 OXA producing iso-
lates, five of the seven NDM-1 producing isolates and 
one VIM-2 positive isolate were not correctly detectable. 
Even the repeated incubation and measurements did not 
reveal better interpretable results.
a NDM-1/-6
Table 1 continued
Bacterial isolates Enzyme variants
Ambler classification
Carbapenemase variants—genotyped MALDI‑TOF MS‑based 
imipenem hydrolysis 
assay
 E. coli D (n = 1) OXA‑181 (n = 1) (n = 1)
 K. pneumoniae D (n = 1) OXA‑204 (n = 1) (n = 1)
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In our hydrolysis assay we relied solely upon the dis-
appearance of imipenem  +  matrix peak to consider an 
isolate as carbapenemase-producer. Kempf et  al. distin-
guished carbapenemase producing isolates with regard to 
disappearance of imipenem peak or an intact/hydrolyzed 
imipenem ratio of <0.5 [23]. Recent studies consider Liq-
uid Chromatography-Tandem Mass Spectrometry the 
gold standard method for small-molecule detection, and 
its performance is well suited to the detection of small 
amounts of compounds present in highly complex matri-
ces, such as serum or bacterial growth broths [25]. As also 
observed by Kulkarni et al. [25], the effects of ion suppres-
sion on carbapenem detection have not been reported for 
MALDI-TOF, and this could be particularly important 
when test interpretation relies upon the lack of detection 
of a compound. In several studies, the matrix peak has 
been used as an internal standard, but the chemical dif-
ferences between MALDI matrix and carbapenems are 
substantial, and differential ionization effects may not be 
effectively determined without an appropriate internal 
standard.
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